Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic. / Stokholm, Jette; Vogel, Asmus; Johannsen, Peter; Waldemar, Gunhild.
In: Dementia and Geriatric Cognitive Disorders, Vol. 27, No. 4, 2009, p. 361-5.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic
AU - Stokholm, Jette
AU - Vogel, Asmus
AU - Johannsen, Peter
AU - Waldemar, Gunhild
N1 - Keywords: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Data Interpretation, Statistical; Denmark; Depression; Education; Female; Humans; Language; Male; Memory; Memory Disorders; Middle Aged; Neuropsychological Tests; ROC Curve; Reproducibility of Results
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Addenbrooke's Cognitive Examination (ACE) is a cognitive screening test developed to detect dementia. It has been validated in several countries. Validation studies have predominantly included patients with various degrees of dementia and healthy controls. OBJECTIVE: The aim of this study was to evaluate the Danish version of ACE as a screening test for early dementia in an outpatient memory clinic. Further, we wanted to investigate the ability of the ACE to discriminate patients with early Alzheimer's disease (AD) from patients with depression. METHOD: 78 patients with mild AD (MMSE >or=20), 30 non-demented patients diagnosed with depression (originally referred for evaluation of cognitive symptoms), and 63 healthy volunteers, all between 60 and 85 years of age, were included. All patients were given the ACE as a supplement to the standard diagnostic work-up. RESULTS: The cut-off points for optimal trade-off between sensitivity and specificity for ACE were 85/86 (sensitivity 0.99, specificity 0.94). When these cut-off points were applied to the group of depressive patients, the specificity dropped to 0.64, indicating a great overlap in individual test scores for demented and depressed patients. CONCLUSION: The optimal cut-off points for ACE found in this Danish study were close to what is reported in most other European studies. The great overlap in ACE scores for demented and depressed patients emphasize that test scores must be interpreted with great caution when used in diagnostic work-up.
AB - BACKGROUND: Addenbrooke's Cognitive Examination (ACE) is a cognitive screening test developed to detect dementia. It has been validated in several countries. Validation studies have predominantly included patients with various degrees of dementia and healthy controls. OBJECTIVE: The aim of this study was to evaluate the Danish version of ACE as a screening test for early dementia in an outpatient memory clinic. Further, we wanted to investigate the ability of the ACE to discriminate patients with early Alzheimer's disease (AD) from patients with depression. METHOD: 78 patients with mild AD (MMSE >or=20), 30 non-demented patients diagnosed with depression (originally referred for evaluation of cognitive symptoms), and 63 healthy volunteers, all between 60 and 85 years of age, were included. All patients were given the ACE as a supplement to the standard diagnostic work-up. RESULTS: The cut-off points for optimal trade-off between sensitivity and specificity for ACE were 85/86 (sensitivity 0.99, specificity 0.94). When these cut-off points were applied to the group of depressive patients, the specificity dropped to 0.64, indicating a great overlap in individual test scores for demented and depressed patients. CONCLUSION: The optimal cut-off points for ACE found in this Danish study were close to what is reported in most other European studies. The great overlap in ACE scores for demented and depressed patients emphasize that test scores must be interpreted with great caution when used in diagnostic work-up.
U2 - 10.1159/000209271
DO - 10.1159/000209271
M3 - Journal article
C2 - 19299896
VL - 27
SP - 361
EP - 365
JO - Dementia and Geriatric Cognitive Disorders
JF - Dementia and Geriatric Cognitive Disorders
SN - 1420-8008
IS - 4
ER -
ID: 19978190